Singapore markets closed

Zentalis Pharmaceuticals, Inc. (ZNTL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.7000-0.2500 (-6.33%)
At close: 04:00PM EDT
3.7000 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
40,560
0
0
0
0
-
Operating expenses
Research development
190,591
189,590
172,734
175,601
84,901
-
Selling general and administrative
63,722
64,351
54,553
40,941
33,886
-
Total operating expenses
254,313
253,941
227,287
216,542
118,787
-
Operating income or loss
-213,753
-253,941
-227,287
-216,542
-118,787
-
Total other income/expenses net
7,888
-22,951
5,987
51,983
683
-
Income before tax
-205,865
-276,892
-221,300
-164,559
-118,104
-
Income tax expense
-566
-601
-469
-297
444
-
Income from continuing operations
-219,003
-292,305
-237,113
-166,093
-118,548
-
Net income
-218,904
-292,191
-236,806
-158,725
-117,841
-
Net income available to common shareholders
-218,904
-292,191
-236,806
-158,725
-117,841
-
Basic EPS
-4.56
-
-4.48
-3.72
-4.19
-1.39
Diluted EPS
-4.56
-
-4.48
-3.72
-4.19
-1.39
Basic average shares
62,234
-
52,857
42,688
28,113
32,874
Diluted average shares
62,234
-
52,857
42,688
28,113
32,874